Concepedia

Author

Hana Žižková

Institute of Haematology and Blood TransfusionORCID

Also Known As

H Zizková, H. ZIZKOVA, H. Zizkova, Hana Zizkova, Hana Žižková

34

Publications

211

Citations

9

H-Index

34

Concepts

All Affiliations

Institute of Haematology and Blood TransfusionUniversity of SouthamptonWessex Regional Genetics LaboratoryCharles UniversitySalisbury NHS Foundation Trust
HŽ

About

Hana Žižková is an author at Institute of Haematology and Blood Transfusion specializing in medicine, hematology, and molecular diagnostics.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

4

4

77

2

Cell Biology

2

2

38

3

Engineering

1

1

29

4

Health Sciences

1

1

29

5

Blood Transplantation

1

1

29

Hana Žižková

×

9

Publications

192

Citations

9

H-Index

YearCitations

Standardization of molecular monitoring of CML: results and recommendations from the European treatment and outcome study

Helen White, Matthew Salmon, Francesco Albano,

Leukemia

2022

34

Unrelated partially matched lymphocyte infusions in a patient with complete DiGeorge/CHARGE syndrome

Aleš Janda, Petr Sedláček, Ester Mejstříková,

Pediatric Transplantation

2007

29

Analysis of chronic myeloid leukaemia during deep molecular response by genomic PCR: a traffic light stratification model with impact on treatment-free remission

Kateřina Machová Poláková, Hana Žižková, Jan Zuna,

Leukemia

2020

29

Monitoring of methylation changes in 9p21 region in patients with myelodysplastic syndromes and acute myeloid leukemia

Hana Cechova, Petra Laššuthová, Ludmila Nováková,

Neoplasma

2011

28

Enzymatically produced piggyBac transposon vectors for efficient non-viral manufacturing of CD19-specific CAR T cells

Iva Kaštánková, Martin Štach, Hana Žižková,

Molecular Therapy — Methods & Clinical Development

2021

18

Assessment of droplet digital polymerase chain reaction for measuring <i>BCR‐ABL1</i> in chronic myeloid leukaemia in an international interlaboratory study

Stuart Scott, Ashley Cartwright, Sebastian Francis,

British Journal of Haematology

2021

17

Impact of BCR::ABL1 transcript type on RT-qPCR amplification performance and molecular response to therapy

Matthew Salmon, Helen E. White, Hana Žižková,

Leukemia

2022

17

Results of the European survey on the assessment of deep molecular response in chronic phase CML patients during tyrosine kinase inhibitor therapy (EUREKA registry)

Susanne Möbius, Thomas Schenk, Danny Himsel,

Journal of Cancer Research and Clinical Oncology

2019

10

Sensitivity and reliability of DNA-based mutation analysis by allele-specific digital PCR to follow resistant BCR-ABL1-positive cells

Václava Polívková, Adela Benesova, Hana Žižková,

Leukemia

2021

10

Page 1